Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategiesValentina Cordo’(Princess Máxima Center), Jules P.P. Meijerink(Erasmus MC - Sophia Children’s Hospital)Nature CommunicationsFebruary 25, 202210.1038/s41467-022-28682-1Cited by 31SaveCiteExport RISWatch citationsRelated PapersMEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia|Leukemia|2016|91Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia|Cell Reports|2023|10